Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Neutral
Dividends
Very Weak
Capital Efficiency
Strong
Balance Sheet
Very Strong
Telephone
1.617.341.6100
Address
50 Northern Avenue, Boston, MA 02210
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 362.5 - 510.77
Trade Value (12mth)
US$169,094,243.00
1 week
-1.51%
1 month
-6.24%
YTD
-2.67%
1 year
-12.08%
All time high
519.88
EPS 3 yr Growth
41.80%
EBITDA Margin
45.50%
Operating Cashflow
$5,293m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
411.70
Quick Ratio
0.00
Shares Outstanding (Fully Diluted)
259m
HALO Sector
Healthcare
Next Company Report Date
09-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 14 February 26 | |
| 14 February 26 | |
| 13 February 26 | |
| 05 November 25 | |
| 05 November 25 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 14.05 | -2.08 | 18.4 | | | | ||
EPS (Fully Diluted) | $ | | | | | 13.89 | -2.08 | N/A | | | | ||
Growth | % | | | | | 8.3 | -114.8 | 986 | | | | ||
PE | X | | | | | 28.2 | 966.2 | 25 | | | | ||
EV/EBITDA | X | | | | | 21 | 127 | 19.7 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
